Understanding Spondyloarthritis Pathogenesis: The Promise of Single-Cell Profiling.

Cytometry RNA-seq Single-cell profiling Spatial transcriptomics Spondyloarthritis

Journal

Current rheumatology reports
ISSN: 1534-6307
Titre abrégé: Curr Rheumatol Rep
Pays: United States
ID NLM: 100888970

Informations de publication

Date de publication:
16 Jan 2024
Historique:
accepted: 28 12 2023
medline: 16 1 2024
pubmed: 16 1 2024
entrez: 16 1 2024
Statut: aheadofprint

Résumé

Single-cell profiling, either in suspension or within the tissue context, is a rapidly evolving field. The purpose of this review is to outline recent advancements and emerging trends with a specific focus on studies in spondyloarthritis. The introduction of sequencing-based approaches for the quantification of RNA, protein, or epigenetic modifications at single-cell resolution has provided a major boost to discovery-driven research. Fluorescent flow cytometry, mass cytometry, and image-based cytometry continue to evolve. Spatial transcriptomics and imaging mass cytometry have extended high-dimensional analysis to cells in tissues. Applications in spondyloarthritis include the indexing and functional characterization of cells, discovery of disease-associated cell states, and identification of signatures associated with therapeutic responses. Single-cell TCR-seq has provided evidence for clonal expansion of CD8+ T cells in spondyloarthritis. The use of single-cell profiling approaches in spondyloarthritis research is still in its early stages. Challenges include high cost and limited availability of diseased tissue samples. To harness the full potential of the rapidly expanding technical capabilities, large-scale collaborative efforts are imperative.

Identifiants

pubmed: 38227172
doi: 10.1007/s11926-023-01132-7
pii: 10.1007/s11926-023-01132-7
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Joerg Ermann (J)

Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA, USA. jermann@bwh.harvard.edu.
Harvard Medical School, Boston, MA, USA. jermann@bwh.harvard.edu.

Micah Lefton (M)

Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.

Kevin Wei (K)

Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Maria Gutierrez-Arcelus (M)

Harvard Medical School, Boston, MA, USA.
Boston Children's Hospital, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Classifications MeSH